BioRestorative Therapies, Inc.
BRTX
$1.57
-$0.04-2.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1,113.20% | -42.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1,113.20% | -42.26% | |||
| Cost of Revenue | 200.00% | -12.12% | |||
| Gross Profit | 1,233.03% | -44.75% | |||
| SG&A Expenses | -55.90% | 190.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.33% | 76.79% | |||
| Operating Income | 31.25% | -78.71% | |||
| Income Before Tax | 50.25% | -226.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 50.25% | -226.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 50.25% | -226.37% | |||
| EBIT | 31.25% | -78.71% | |||
| EBITDA | 31.61% | -80.16% | |||
| EPS Basic | 52.44% | -217.28% | |||
| Normalized Basic EPS | 52.44% | -6,984.48% | |||
| EPS Diluted | 52.44% | -216.34% | |||
| Normalized Diluted EPS | 52.44% | -6,984.48% | |||
| Average Basic Shares Outstanding | 4.59% | 2.85% | |||
| Average Diluted Shares Outstanding | 4.59% | 2.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||